BIO-PATH HOLDINGS INC

For the period ended Dec 31, 2023. Filed Mar 7, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 7, 2024

BPTH$0.21-66.8%Stored close · as of Feb 18, 2025

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 8. Consolidated Statements of Cash Flows

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)


· · Year Ended December 31,
· · 2023 · · 2022
Cash flow from operating activities · ·
· ·
Net loss	$(16,078)	$(13,868)

Adjustments to reconcile net loss to net cash used in operating activities

Stock-based compensation	734	851
Amortization of right of use assets	96	90
Depreciation	82	88
Change in fair value of warrant liability	271	—
(Increase) decrease in operating assets
Prepaid drug product	2,955	(3,064)
Other current assets	286	199
Increase (decrease) in operating liabilities
Accounts payable and accrued expenses	227	700
Lease liabilities	(108)	(99)

Net cash used in operating activities	(11,535)	(15,103)

Cash flow from investing activities

Purchases of furniture, fixtures & equipment	—	(21)

Net cash used in investing activities	—	(21)

Cash flow from financing activities

Net proceeds from sale of common stock	1,677	1,734
Net proceeds from exercise of warrants	526	—

Net cash provided by financing activities	2,203	1,734

Net decrease in cash	(9,332)	(13,390)

Cash, beginning of period	10,384	23,774

Cash, end of period	$1,052	$10,384

Supplemental disclosure of non-cash activities

Non-cash operating activities
Right of use asset recognized in exchange for lease obligation	$—	$85

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.